We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.62%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$483M
AUM Growth
+$36.3M
(+8.1%)
Cap. Flow
+$48.7M
Cap. Flow
% of AUM
10.09%
Top 10 Holdings %
Top 10 Hldgs %
39.82%
Holding
168
New
65
Increased
31
Reduced
19
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLT
CATALENT, INC.
CTLT
|
+$11.4M |
| 2 |
Itron
ITRI
|
+$9.25M |
| 3 |
Fluor
FLR
|
+$8.9M |
| 4 |
Pacific Biosciences
PACB
|
+$7.8M |
| 5 |
First Solar
FSLR
|
+$6.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$12.3M |
| 2 |
Tenet Healthcare
THC
|
+$10.3M |
| 3 |
CTLP
Cantaloupe
CTLP
|
+$9.1M |
| 4 |
Pacira BioSciences
PCRX
|
+$9.04M |
| 5 |
Guardant Health
GH
|
+$8.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.4% |
| 2 | Industrials | 8.27% |
| 3 | Healthcare | 8.06% |
| 4 | Materials | 7.9% |
| 5 | Utilities | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
101
Bed Bath & Beyond
BBBY
$472M
| $440K | 0.09% |
+25,025
| New | +$538K |
|
102
CALL
Ambarella
AMBA
$3.25B
| $411K | 0.09% |
+5,000
| New | +$333K |
|
103
CALL
Roku
ROKU
$21.5B
| $407K | 0.08% |
10,000
| – | – |
|
104
LSB Industries
LXU
$794M
| $399K | 0.08% |
+30,000
| New | +$447K |
|
105
FerroAtlántica
GSM
$600M
| $393K | 0.08% |
102,000
+25,000
| +32% | +$124K |
|
|
FTCH
106
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $385K | 0.08% |
+81,500
| New | +$568K |
|
107
OPAL Fuels
OPAL
$67.4M
| $381K | 0.08% |
+52,301
| New | +$422K |
|
108
Toast
TOST
$19.1B
| $278K | 0.06% |
+15,400
| New | +$289K |
|
109
Magnite
MGNI
$2.78B
| $262K | 0.05% |
+24,750
| New | +$226K |
|
110
CALL
AdvisorShares Pure US Cannabis ETF
MSOS
$854M
| $245K | 0.05% |
+35,000
| New | +$360K |
|
|
FTCH
111
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $237K | 0.05% |
+50,000
| New | +$348K |
|
112
CALL
NCR Voyix
VYX
$1.12B
| $234K | 0.05% |
+16,300
| New | +$217K |
|
|
113
Roku
ROKU
$21.5B
| $189K | 0.04% |
4,650
-9,350
| -67% | -$489K |
|
114
Energy Fuels
UUUU
$2.93B
| $155K | 0.03% |
+25,000
| New | +$166K |
|
|
ZUO
115
CALL
DELISTED
Zuora, Inc.
ZUO
| $146K | 0.03% |
+23,000
| New | +$163K |
|
|
VISN
116
PUT
Vistance Networks Inc
VISN
$2.64B
| $110K | 0.02% |
+15,000
| New | +$145K |
|
|
TRUE
117
DELISTED
TrueCar
TRUE
| $25.1K | 0.01% |
+10,000
| New | +$20.8K |
|
118
CALL
Barnes & Noble Education
BNED
$430M
| $17.5K | ﹤0.01% |
+100
| New | +$23.8K |
|
119
General Motors
GM
$80B
| $16.8K | ﹤0.01% |
500
+350
| +233% | +$12.9K |
|
120
PUT
Apple
AAPL
$4.9T
| – | – |
-12,000
| Closed | -$1.66M |
|
121
Advanced Micro Devices
AMD
$791B
| – | – |
-6,150
| Closed | -$390K |
|
122
AstraZeneca
AZN
$266B
| – | – |
-50,000
| Closed | -$5.48M |
|
|
CTRA
123
DELISTED
Coterra Energy
CTRA
| – | – |
-170,000
| Closed | -$4.53M |
|
124
CALL
DXC Technology
DXC
$1.82B
| – | – |
-50,000
| Closed | -$1.22M |
|
|
125
DXC Technology
DXC
$1.82B
| – | – |
-4,000
| Closed | -$98K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
FWM
Ardsley Advisory Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Ardsley Advisory Partners held 168 positions worth $483M, up 8.1% from $447M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Ardsley Advisory Partners deployed $48.7M of net new capital in Q4 2022, opening 65 new positions and adding to 31 existing holdings. Its largest new stake was CATALENT, INC.: 210,500 shares worth $9.48M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Cantaloupe, an estimated $9.1M trimmed.
- Ardsley Advisory Partners's largest Q4 2022 buy was CATALENT, INC.: 210,500 shares worth $9.48M.
- Ardsley Advisory Partners added most to Itron in Q4 2022, an estimated $9.25M increase.
- Ardsley Advisory Partners's biggest Q4 2022 reduction was Cantaloupe, cutting an estimated $9.1M.
- Ardsley Advisory Partners fully exited STAAR Surgical in Q4 2022, selling an estimated $12.3M.
- Ardsley Advisory Partners's ten largest holdings make up 40% of its $483M portfolio in Q4 2022.
- Ardsley Advisory Partners opened 65 new positions and closed 49 in Q4 2022.
- Ardsley Advisory Partners's portfolio value rose 8.1% quarter-over-quarter to $483M.
Based on Ardsley Advisory Partners's 13F filing for Q4 2022, filed 14 Feb 2023.